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Abstract
Background—Pesticide exposures are ubiquitous and of substantial public concern. We 
examined the potential association of congenital heart defects with residential proximity to 
commercial agricultural pesticide applications in the San Joaquin Valley, California.
Methods—Study subjects included 569 heart defect cases and 785 non-malformed controls born 
from 1997 to 2006 whose mothers participated in a population-based case-control study. 
Associations with any versus no exposure to physicochemical groups of pesticides and specific 
chemicals were assessed using logistic regression adjusted for relevant covariates, for 8 heart 
defect phenotypes that included ≥50 cases and pesticide exposures with ≥5 exposed cases and 
controls, which resulted in 235 comparisons.
Results—38% of cases and controls were classified as exposed to pesticides within a 500 m 
radius of mother's address during a 3-month periconceptional window. Adjusted odds ratios 
(AORs) with 95% CIs excluding 1.0 were observed for 18 comparisons; all were >1 and ranged 
from 1.9 to 7.1. They included tetralogy of Fallot (n = 101 cases) and neonicotinoids; hypoplastic 
left heart syndrome (n = 59) and strobins; coarctation of the aorta (n = 74) and pyridazinones; 
pulmonary valve stenosis (n = 53) and bipyridyliums and organophosphates; ventricular septal 
defects (n = 93) and avermectins and pyrethroids; and atrial septal defects (n = 132) and 
dichlorphenoxy acid or esters, organophosphates, organotins, and pyrethroids. No AORs met both 
of these criteria for D-transposition of the great arteries (n = 58) or heterotaxia (n = 53).
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Conclusions—Most pesticides were not associated with increased risk of specific heart defect 
phenotypes. For the few that were associated, results should be interpreted with caution until 
replicated in other study populations.
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1. Introduction
Congenital heart defects (CHDs) are the most common broad grouping of structural birth 
defects, affecting close to one percent of infants and comprising close to a third of all infants 
with birth defects (Bjornard et al., 2013). CHDs include a variety of phenotypes with 
differing pathogeneses and likely etiologies. In general, a combination of environmental and 
genetic factors likely contributes to the etiologies of CHDs, but beyond that, our knowledge 
is relatively limited. Some known risk factors for CHDs include maternal race-ethnicity, age, 
smoking, diabetes, and use of some medications, but specific associations vary for different 
specific phenotypes (Patel and Burns, 2013).
Exposure to pesticides is ubiquitous, and public concern regarding their potential harmful 
effects is extensive. Some experimental studies suggest that certain pesticides are teratogenic 
(Kopf and Walker, 2009). However, associations from human studies are few and not clear 
(Wigle et al., 2008). Pesticides comprise a variety of different chemicals, with varying 
biologic effects, and with varied routes of exposure, making it challenging to study human 
exposure. Pesticides and other environmental chemical exposures have been suggested to be 
associated with CHDs but evidence is too limited to draw conclusions (Wigle et al., 2008). 
Few studies have examined specific CHD phenotypes (Correa-Villasenor et al., 1991; 
Erickson et al., 1984; Loffredo et al., 2001; Shaw et al., 1999; Tikkanen and Heinonen, 
1990; Wilson et al., 1998), which is important given potential etiologic heterogeneity by 
phenotype. Previous studies relied on self-reported, broad categories of exposure (e.g., lived 
near agricultural crops or used pesticides at home or work). None of them examined 
exposure to specific chemicals.
For this study, we examined whether residential proximity to applications of specific 
pesticide chemicals was associated with risk of specific CHD phenotypes. To do this, we 
linked detailed data on CHD phenotypes from a population-based birth defects registry with 
detailed publicly available data regarding commercial agricultural applications of pesticides. 
We determined which specific pesticides were applied within a 500 m radius of the mother's 
residential address during early pregnancy, when heart development takes place. Births 
occurred in the San Joaquin Valley of California, one of the highest pesticide use areas in the 
U.S.
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The California Center of the National Birth Defects Prevention Study (NBDPS) is a 
collaborative partnership between Stanford University and the California Birth Defects 
Monitoring Program in the Department of Public Health (Yoon et al., 2001). Since 1997, the 
Center has collected data from women whose residence at the time of delivery was one of 
eight counties in the San Joaquin Valley. The California Birth Defects Monitoring Program 
is a well-known surveillance program that is population-based (Croen et al., 1991). To 
identify cases with birth defects, data collection staff visit all hospitals with obstetric or 
pediatric services, cytogenetic laboratories, and all clinical genetics prenatal and postnatal 
outpatient services. This analysis included study subjects with estimated dates of delivery 
from October 1, 1997 to December 31, 2006. The study protocol was reviewed and approved 
by the institutional review boards of Stanford University and the California Department of 
Public Health.
Cases included infants or fetuses with CHDs confirmed by echocardiography, cardiac 
catheterization, surgery, or autopsy reports. Most diagnoses occurred in the first year. A 
central team of clinicians with expertise in pediatric cardiology and medical genetics 
reviewed the available clinical documentation to code and classify the CHDs of each case 
infant, as described (Rasmussen et al., 2003). Briefly, each infant's CHDs were classified 
into one of three categories: simple, association, or complex, depending on the cardiac 
phenotype. For example, an infant with perimembranous ventricular septal defect but 
without any other cardiac abnormality would be classified as simple. If a secundum atrial 
septal defect was also present, it would be classified as an association. A ventricular septal 
defect in the context of a single ventricle phenotype (e.g., double inlet left ventricle) would 
not be classified or counted as a ventricular septal defect, but only as a single ventricle, 
double inlet left ventricle type. The complex category includes a small group of phenotypes 
with multiple structural cardiac findings, as can occur for heterotaxy or certain single 
ventricle phenotypes (Rasmussen et al., 2003). Eligible cases of heterotaxy were those with 
major eligible CHDs associated with situs ambiguous or situs inversus. To improve case 
homogeneity, analyses focused on CHDs classified as simple, with the inclusion of 
heterotaxy, which was classified as complex. Cases recognized or strongly suspected to have 
single-gene disorders, chromosomal aneuploidy, or identifiable syndromes were ineligible, 
assuming that their etiologies are known. We included eight CHD phenotypes for which we 
had maternal interviews and pesticide exposures data (see below) for at least 50 cases: 
heterotaxia, tetralogy of Fallot, D-transposition of the great arteries, hypoplastic left heart 
syndrome, coarctation of the aorta, pulmonary valve stenosis, perimem-branous ventricular 
septal defect (VSD), and atrial septal defect (ASD) secundum.
Controls included non-malformed live-born infants randomly selected from birth hospitals to 
represent the population from which the cases arose. That is, we selected approximately 150 
controls per study year, such that their distribution by hospital was proportional to the 
underlying birth population. Maternal interviews were conducted using a standardized, 
computer-based questionnaire, primarily by telephone, in English or Spanish, between 6 
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weeks and 24 months after the infant's estimated date of delivery. Interviews were conducted 
with mothers of 70% of eligible cases (n = 704) and 69% of controls (n = 974). Interviews 
were completed within an average of 12 months from estimated date of delivery for cases 
and 8 months for controls. Because poorly managed pregestational diabetes (i.e. type I or II) 
has been associated with increased risk of birth defects (Correa et al., 2008), cases (n = 30) 
and controls (n = 7) whose mothers had diabetes were excluded from analyses. Mothers 
reported their residential history from 3 months before conception through delivery, 
including dates and residences occupied for more than 1 month.
2.2. Selection of pesticide compounds
We assessed exposure to 461 individual chemicals and 62 physicochemical groupings 
having the same chemical classification and proven or putative mechanism of action (e.g., 
organophosphates) that were applied at >100 lb in any of eight SJV counties in any year 
during the study period (1997–2006) (Kegley et al., 2011). Low-toxicity chemicals such as 
biopesticides (e.g., microbial pesticides, soaps, essential oils), low-toxicity inorganic 
compounds (e.g., sulfur), and other compounds determined by US EPA to have low toxicity, 
as described in US EPA Risk Assessment documents for each chemical were excluded 
(Agency, 2012). In addition, compounds were flagged as having reproductive or 
developmental toxicity based on the California Proposition 65 list or as endocrine disruptors 
(California Office of Environmental Health Hazard Assessment, 2012; Colborn, 1996; 
European-Commission, 2000; Keith, 1997). Chemicals with a US EPA-determined 
Reference Dose (RfD) based on a toxicological study with a reproductive or developmental 
endpoint as described in EPA risk assessment documents were also included (Agency, 
2012).
2.3. Pesticide exposure assessment
Off-site transport of pesticides occurs via airborne drift of aerosols and dust particles from 
spray applications (spray drift), post-application volatilization drift from evaporation of 
semi-volatile and volatile pesticides from leaf and soil surfaces, and leaching through soils 
into groundwater. Thus, proximity to pesticide use is one measure of exposure that can occur 
through inhalation of volatilized pesticides and spray drift and incidental oral exposures 
from contaminated house dust. For this analysis, pesticide use is considered to be a proxy for 
exposure via spray drift and volatilization drift.
For each case or control mother, we estimated pesticide exposure from 1 month before to 2 
months after her reported date of conception (B1-P2), which is inclusive of the time period 
of heart development. The California Environmental Health Tracking Program (CEHTP) 
Geocoding Service was used to geocode study each subject's residences corresponding to 
this time window (California Environmental Health Tracking Program, 2012b). The CEHTP 
Geocoding Service standardizes, verifies, and corrects addresses before matching against 
multiple address-attributed reference databases. Geocoding was successful for 87% of cases 
(585 of 674) and 83% of controls (807 of 967). Exposure assignments were made for 569 
heart defect cases and 785 controls whose mothers lived at the geocoded addresses more 
than 68 days during B1-P2 (i.e., at least 75% of the 3-month window). For those mothers 
Carmichael et al. Page 4













who reported multiple addresses, days at each address were used as the weighting for 
exposure assignment.
To estimate pesticide applications, we obtained statewide Pesticide Use Reporting (PUR) 
records from the California Department of Pesticide Regulation describing agricultural 
pesticide applications occurring between 1 January 1997 and 31 December 2006. These data 
are submitted by county agriculture commissioners and are spatially referenced to public 
land survey sections (PLSS). During the 10-year study period, the total number of active 
ingredient daily production agricultural use records with a public land survey section 
specified, and for the 461 chemicals that were present in PUR records, was 23,883,704. 
Following the method of Rull and Ritz (2003), we spatially refined PLSS polygons through 
overlay of matched land-use survey field polygons provided by the California Department of 
Water Resources; that is, we refined the pesticide application to a specific polygon, which is 
smaller than the 1-square-mile area of the PLSS polygon. We matched each PUR record to 
the land-use survey conducted closest in time to the application date (surveys are conducted 
roughly every 5–7 years in each California county). Matching is based on location and crop 
type as specified in records. Infrequently rotated crops, such as orchard crops and vineyards, 
were matched one-to-one, while frequently rotated crops, such as field and truck crops, were 
grouped together in a single category, and non-agricultural land-uses were subtracted from 
PLSS polygons when no crop types were matched to available polygons. Of the total 
applications (and active-ingredient poundage) recorded spanning 1997–2006 for the 461 
chemicals of interest, 91.3% (92.1% by poundage) were successfully linked to polygons – 
31.8% (42.0% by poundage) were matched on individual crop, 56.4% (46.9% by poundage) 
were under the “frequently rotated” category, and 3.0% (3.1% by poundage) were refined, 
subtracting non-agricultural land-use polygons from PLSS polygons. For the remaining 
8.7% of applications (7.9% by poundage), no field polygon was specified and therefore no 
spatial refinement was possible. We determined temporal proximity by comparing recorded 
dates of applications (which are believed to be accurate within a few days) to the appropriate 
time window for each study subject.
To assign exposure, we utilized the CEHTP Pesticide Linkage Tool, a custom-developed 
Java (Oracle, Redwood Shores, CA) application which incorporates the GeoTools Java GIS 
Toolkit, version 2.7.1 (open source, http://geotools.codehaus.org/) for GIS data management 
and spatial analysis (California Environmental Health Tracking Program, 2012a). We 
calculated pounds of pesticides used during the relevant time window within a 500 m radius 
of a geocoded point, intersecting polygons with the buffer, and assuming homogeneous 
distribution of pesticides within each polygon (Roberts et al., 2007).
2.4. Air pollutants exposure assessment
In an earlier investigation we explored daily metrics of the following air pollutants: carbon 
monoxide (CO), nitrogen oxide (NO), nitrogen dioxide (NO2), ozone (O3), particulate 
matter ≤ 10 µm (PM10), and PM ≤ 2.5 µm (PM2.5) in aerodynamic diameter. Details of this 
work can be found elsewhere (Padula et al., 2013). We further considered these measures in 
the current analysis as a means of capturing a more comprehensive environmental exposure 
burden. Briefly, employing ambient air quality data collected routinely at over 20 locations 
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in the San Joaquin Valley by the US EPA's Air Quality System database (www.epa.gov/ttn/
airs/airsaqs), we estimated quartile levels among the controls of CO, NO, NO2, O3, PM10, 
and PM2.5. We also estimated traffic density measures from distance-decayed annual 
average daily traffic volumes within a 300 m radius of geo-coded maternal residences using 
the CEHTP web-based traffic volume linkage tool (www.cehtp.org/page.jsp?page_key=136).
2.5. Statistical analysis
Risks associated with pesticide exposures were estimated using logistic regression. Analyses 
estimated odds ratios and 95% confidence intervals (CI) reflecting associations between any 
versus no exposure to each pesticide or pesticide group of interest and selected CHDs. 
Associations of any versus no exposure to any pesticide with numerous covariates (maternal 
education, prepregnancy body mass index, use of folic acid-containing supplements, 
smoking, or alcohol drinking, parity, plurality) were examined in bivariate analyses among 
785 controls; no substantial associations were observed (results not shown). However, based 
on previous reported risk factors for CHDs, we adjusted odds ratios for race/ethnicity (non-
Hispanic white, U.S.-born Hispanic, foreign-born Hispanic, other), education (less than high 
school, high school, more than high school), age at delivery (year, continuous), any (versus 
none) intake of folic acid-containing supplements, alcohol, and smoking during the month 
before or the first two months of pregnancy.
To focus on comparisons likely to have the most precise risk estimates and to fully utilize 
available data, we did the following. Only heart defect groupings with at least 50 cases 
(described above; 569 total cases) were included in risk estimation, and adjusted odds ratios 
(AORs) were estimated only for pesticide chemicals or chemical groups that had at least 5 
exposed cases and 5 exposed controls. In addition, we created overall exposure scores by 
summing the total number of chemicals or groups, endocrine disruptors, Proposition 65 
chemicals, or EPA reproductive or developmental toxicants to which each case or control 
was exposed. We examined the association of specific heart phenotypes with these scores 
specified as categorical variables (exposed subjects were divided into tertiles based on the 
control distributions).
After following the sample size criteria described above, we were left with a large number of 
comparisons (see below). To guard against multiple testing error, we further stipulate that all 
reportable odds ratios must (1) have confidence intervals excluding 1.0 or (2) be less than or 
equal to 0.5 or greater than or equal to 2.0. (Results that did not meet these criteria are 
available upon request.) Analyses were conducted using SAS 9.3 (SAS Institute Inc., Cary, 
NC, 2012–2013).
3. Results
Comparisons of various descriptive factors between the 785 control mothers and the mothers 
of the overall grouping of 569 CHD case infants did not reveal substantive differences (Table 
1).
Women were exposed to 53 groups of chemicals and 248 individual chemicals during the 
month before or first two months of pregnancy based on residential proximity within 500 m 
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of pesticide applications. Overall, 38.1% of control mothers (299/785) and 38.0% of case 
mothers (216/569) had any periconceptional pesticide exposure. The five chemical groups to 
which control mothers were most frequently exposed (i.e., any versus no use near their 
residence) were polyalkyloxy compounds (polymers made by condensation of ethylene 
oxide and an alcohol, used as adjuvants) (25%), phosphonoglycine herbicides (22%), 
organophosphorus insecticides (17%), simple alcohols/ethers (17%), and pyrethroids (14%).
We estimated AORs only for chemicals or chemical groups for which at least 5 case mothers 
and 5 control mothers were exposed. Table 2 shows the number of chemical groups and 
specific chemicals that met this criterion for risk estimation by specific CHD phenotype.
Table 2 also shows the number of cases per phenotype, which ranged from 53 to 132.
Tables 3 and 4 show AORs that met our criteria of being ≥ 2.0 or ≤ 0.5 or having confidence 
intervals that excluded 1.0. Adjusted odds ratios (AORs) with 95% CIs excluding 1.0 were 
observed for 18 comparisons; all were >1 and ranged from 1.9 to 7.1.
Chemical groups with confidence intervals that excluded 1.0 were observed for: tetralogy of 
Fallot with neonicotinoids, hypoplastic left heart syndrome with strobins, coarctation of the 
aorta with pyridazinones, pulmonary valve stenosis with bipyridyliums and 
organophosphates, ventricular septal defects with avermectins, and atrial septal defects with 
dichlorophenoxy acid salts or esters (Table 3). AORs ranged from 2.3 to 2.9.
Specific chemicals that had AORs with confidence intervals excluding 1.0 ranged from 1.9 
to 7.1 and were observed for tetralogy of Fallot (imidacloprid, a neonicotinoid), hypoplastic 
left heart syndrome (azoxystrobin, a strobin), coarctation of the aorta (norflurazon, a 
pyridazinone), pulmonary valve stenosis (2,4-D, dimethylamine salt, a dichlorophenoxy acid 
salt; and paraquat dichloride, a bipyridylium compound); ventricular septal defects 
(abamectin, an avermectin); and atrial septal defects (hexazinone; 2,4-D, dimethylamine salt, 
a dichlorophenoxy acid or ester; chlorpyrifos, an organophosphate; fenbutatin-oxide, an 
organotin; and lambda-cyhalothrin, a pyrethroid) (Table 4).
Scores reflecting the number of pesticides to which women were exposed did not suggest an 
increasing risk associated with increasing numbers of pesticides (data not shown). Analyses 
examining combinations of pesticide and air pollutant exposures also did not suggest 
increasing risk with these combined exposures relative to neither (data not shown).
4. Discussion
We examined the association of residential proximity to commercial applications of 
pesticides with risks of specific types of CHDs among offspring of women living in the San 
Joaquin Valley of California, one of the highest pesticide-use areas in the U.S. Thirty-eight 
percent of women lived within 500 m of a pesticide application during the periconceptional 
period and were classified as having exposure to 53 groups of chemicals and 248 specific 
chemicals. Among the chemicals with sufficiently common exposure to merit risk estimation 
few were associated with substantially increased risk. Among those that were, results should 
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be interpreted with caution, given the possibility of chance as an alternate explanation 
because of the relatively large number of comparisons that were made.
Few studies have examined risks of CHDs and pesticide exposures. Their results as well as 
their methods have varied. For example, a study in Finland reported that occupation-related 
exposure to pesticides was not associated with hypoplastic left heart syndrome (Tikkanen 
and Heinonen, 1990). A U.S. study reported that overall prevalence of heart malformations 
was not higher in high wheat-producing counties (a proxy for exposure to chorophenoxy 
herbicides) (Schreinemachers, 2003). Other U.S. studies suggested conotruncal heart defects 
(which include D-transposition of the great arteries and tetralogy of Fallot) were associated 
with self-reported pesticide exposures via household or occupational use (Loffredo et al., 
2001; Shaw et al., 1999). We are unaware of previous epidemiologic investigations of 
associations of more specific pesticide chemical exposures with CHDs overall or their 
specific sub-phenotypes. One study reported an association of the antifungal medication 
fluconazole with certain heart defects (Molgaard-Nielsen et al., 2013). We observed an 
association of azoles, a group of widely used crop fungicides, with coarctation of the aorta; 
this phenotype was not examined in the fluconazole study. We observed associations of 
tetralogy of Fallot with neonicotinoids and of hypoplastic left heart syndrome with strobins. 
Use of these two classes of chemicals has increased in recent years (DPR, 2014). We were 
unable to find published animal teratology studies that observed the specific phenotype-
chemical associations reported in our current study. Some animal studies have observed 
teratogenic effects of pesticide exposures on the developing heart, but they are highly 
variable with regard to specific chemicals and specific heart defects investigated (Kopf and 
Walker, 2009). Given this variability, as well as limitations inherent to applying animal 
studies to humans, we do not propose more specific connections between our findings and 
experimental studies.
Strengths of the current study include the population-based design, large numbers of infants 
with specific heart defect phenotypes, maternal residential addresses from the relevant 
embryonic time period, data on many potential covariates, and pesticide exposure 
assessment that was spatially and temporally specific and encompassed a broad spectrum of 
specific pesticide compounds. An important limitation was the modest sample sizes for 
many comparisons, which limited the precision of the estimates and their attendant 
inferences. In addition, the exposure assessment did not take into account other factors that 
may affect actual exposures (e.g., chemical half-lives and vapor pressure, wind patterns, an 
individual's ability to metabolize the chemicals, and other sources of pesticide exposure such 
as occupation or home use). It is notable however that most pesticides are prone to drift and 
detectable in air samples at locations beyond the application site (Kegley et al., 2011), and 
residential proximity to pesticide-treated fields has been associated with household dust and 
urine levels (Fenske et al., 2005; Simcox et al., 1995). Errors in exposure assessment may 
have occurred due to variable amounts of time away from home but we do not have reason 
to believe that this time would have varied systematically for cases versus controls.
We made 235 comparisons (although the number per phenotype ranged from 16 to 50). 
Given our goal to perform a hypothesis-generating study, we did not correct results for 
multiple comparisons or restrict presentation of results to strict criteria of statistical 
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significance. Thus, the results we have highlighted should be interpreted with caution. We 
would also like to note, however, that a fundamental property of false positive findings 
generated through multiple testing is that the resulting coefficients should be distributed 
symmetrically around zero. Our results depart from this symmetry, i.e., no negative 
coefficients meeting our reporting criteria. Although the departure from symmetry does not 
exclude the possibility that some results may arise from multiple testing, it adds some 
credibility to the idea that residential proximity to pesticide applications or some unknown 
confounding variable may be associated with cardiac organogenesis.
Results of this study do not in general indicate strong associations of specific CHDs with 
residential proximity to pesticide applications. These findings were in the context of a high-
pesticide use area of the U.S. The study investigated several specific CHD phenotypes and 
exposure to specific chemicals, which has not been the case for most previous studies of 
CHDs and environmental exposures. Results regarding observed associations with specific 
chemicals or groups of chemicals require further inquiry and verification before firm 
conclusions can be reached regarding potential teratogenicity.
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Table 1






  White 31 33
  U.S.-born Hispanic 22 25
  Foreign-born Hispanic 33 28
  Other 14 14
Maternal age at delivery
  (years)
  <20 12 17
  20–24 25 28
  25–29 31 26
  30–34 20 18
  >35 11 10
Maternal education (years)
  < 12 33 30
  12 29 28
  > 12 37 41
Parity
  0 33 37
  1 30 31
  2+ 37 32
Prepregnancy BMI (kg/m2)
  Underweight BMI ( < 18.5) 5 5
  Normal weight
  (18.5 ≤ BMI < 25)
44 47
  Overweight
   (25 ≤ BMI < 30)
23 24
  Obese ( ≥ 30) 22 18
Multi-vitamin Useb
  Yes 64 64
  No 35 34
Smokingb
  None 86 85
  Any 14 15
Drinkingb
  None 73 69
  Any 27 31
Plurality
  Singletons 95 99
a
Percentages may not equal 100 owing to rounding or missing data.
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b
During the month before or the first two months of pregnancy.
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Table 2
Percent of cases exposed to pesticides and number of chemical groups and specific chemicals that met case 
count criteria for risk estimationa, San Joaquin Valley of California, 1997–2006.
Heart defect No. of cases No. (percent) of cases with
any pesticide exposure
No. of chemical groups No. of specific chemicals
Heterotaxia 53 21(39.6%) 9 7
Tetralogy of Fallot 101 37(36.6%) 18 22
D-Transposition of the great arteries 58 20(34.5%) 11 9
Hypoplastic left heart syndrome 59 24(40.7%) 15 12
Coarctation of the aorta 74 27(36.5%) 13 16
Pulmonary valve stenosis 53 22(41.5%) 11 10
VSD perimembranous 93 35(37.6%) 15 17
ASD secundum 132 52(39.4%) 20 30
a
For each phenotype, the table shows the number of chemical groups and specific chemicals that had at least 5 exposed cases. Risks were only 
estimated for these chemical groups and specific chemicals. For reference, the study included 785 controls, 299 (38.1%) of whom were exposed to 
pesticides, and a total of 569 cases.
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Table 3
Odds ratios for pesticide chemical groups and congenital heart defects, San Joaquin Valley of California, 
1997–2006.a





Heterotaxia Avermectin 5/48 31/754 2.8(1.0–7.6)
Tetralogy of Fallot Neonicotinoid 10/91 35/750 2.4(1.1–5.1)
Hypoplastic left heart syndrome Strobin 7/52 33/752 2.9(1.2–7.0)
Triazine 8/51 57/728 2.2(1.0–5.1)
Coarctation of the aorta Pyridazinone 6/68 23/762 2.9(1.1–7.5)
Pulmonary valve stenosis Dichlorophenoxy acid or ester 6/47 19/383 2.9(1.0–7.9)
Bipyridylium 11/42 40/362 2.3(1.1–4.9)
Organophosphate 15/38 57/345 2.5(1.2–5.0)
Triazine 6/47 24/378 2.2(0.8–6.0)
Ventricular septal defect, 
perimembranous
Avermectin 10/83 31/754 2.8(1.2–6.2)
Atrial septal defect, secundum Dichlorophenoxy acid or ester 14/118 41/744 2.3(1.2–4.5)
a
AORs are presented for chemicals for which the AOR was ≤ 0.5 or ≥ 2.0 or for which the confidence interval excluded 1.0. ORs were adjusted for 
maternal race/ethnicity, education, age (continuous), and any (versus none) intake of folic acid-containing supplements, alcohol, and smoking 
during the month before and the first two months of pregnancy.
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